Culture Biosciences
Culture Biosciences is seeking a Software Engineer with expertise in automation and controls to design, build, and maintain automation systems for its bioreactor and bioprocessing business. The role involves tuning and troubleshooting control loops, developing reliable automation solutions, and collaborating across software, hardware, and systems teams to improve process performance. This position requires a strong understanding of control theory and the ability to translate process requirements into control logic for complex physical systems.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2016
Culture Biosciences offers an integrated suite of bioprocess development products and services, including Console (cloud-based bioreactor management and data analytics software), Stratyx (mobile laboratory bioreactors), and Nexxys (expert-run bioprocessing services). Their platform enables biotech and biomanufacturing customers to design, monitor, and analyze cell culture experiments remotely, accelerating upstream process development and reducing time to market. By combining cloud-native software, flexible bioreactor hardware, and on-demand lab operations, Culture Biosciences helps customers remove bottlenecks and scale bioprocesses more reliably.
Firm Advises Culture Biosciences on Series C Financing Round
Dec 18, 2025
Cytiva Expands Collaboration with Culture Biosciences
Aug 6, 2025
Culture Biosciences unveils Stratyx™ 250, the first cloud-integrated, mobile bioreactor for cell culture process development
Apr 1, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Culture Biosciences.
10% above the average for this role
Culture Biosciences Raises $80M Series B to Tackle Demand for Large-Scale Biomanufacturing
Oct 14, 2021